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Introduction  
Arthritis is a joint disorder featuring 
inflammation which is frequently accompanied by joint 
pain. Now a day, it is a very common condition due to 
today’s modern life style and early ageing process. 
Because of it many people suffer from number of joint 
diseases which even hamper their routine activities.  
Symptoms of common arthritis include 
swelling, pain, stiffness in joints and decreased range of 
motion. Symptoms may be intermittent or continuous. 
They can be mild, moderate or severe even. The 
condition may remain same for years, or it may 
progress or get worsen over time span. Arthritis can 
cause permanent joint changes resulting in chronic pain, 
inability to do daily activities and make it difficult to 
walk or climb the stairs. 
There are more than 100 different types of 
arthritis and related conditions. People of all ages, 
gender and races can have arthritis and it is the leading 
cause of disability. More than 50 million adults and 
300,000 children have some or the other type of 
arthritis. It is the most common among women and 
occurs more frequently as people gets older. (1) 
The focus of treatment for arthritis is limited to 
control pain, minimize joint damage and improve or 
maintain the function and quality of life. Treatment 
includes analgesics, non-pharmacologic therapies, 
physical or occupational therapies, splints or joint 
assistive measures, patient education and support, 
weight loss, joint replacement and ultimately joint 
surgery. 
In Ayurveda, arthritis is described as sandhivata 
and enlisted under Vata diseases. Various formulations 
and treatment modalities are used to cure sandhivata. 
Apart from the above listed measures, various toxic 
herbal drugs are also mentioned to have good medicinal 
values in this disease. Though the poison is harmful, 
dangerous and life threatening, they are vividly used 
therapeutically as they have quick distributing action 
(2). Hence, they are useful in acute conditions like joint 
pain.  
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Abstract
Background: Life style disorders are an emerging problem in India where various types of arthritis are 
hampering the routine activities of people due to severe pain and inflammation. In such circumstances, everybody 
wants quick relief with the symptoms. Visha dravya used in Ayurveda are known for their quick action. Gunja (Abrus 
precatorius Linn) is a visha indicated in various diseases for internal and external use. Objectives: A randomized 
clinical study was conducted to assess the efficacy of Gunja beeja lepa to manage the local inflammatory conditions 
of Arthritis in comparison with a standard anti-inflammatory Ayurvedic drug Shunthi (Zingiber officinalis Linn) to 
provide a potent anti-inflammatory drug for the purpose of clinical practice. Material and methods: Patients suffering 
from transient mono or bi-arthropathies of knee were applied Gunja beeja lepa in comparison with local application 
of standard anti-inflammatory Ayurvedic drug Shunthi. Assessment was done with the help of Disease Activity Score 
(DAS-28-3) including three variables viz; tender joint score (Range 0-28), Swollen Joint Count (Range 0-28) and 
Erythrocyte sedimentation rate. Statistical comparisons were performed by both paired, unpaired student’s t test by 
using Sigma stat software (version 3.1) for both the experimental the groups at p<0.05 (level of significance). Result: 
Intervention with Gunja beeja lepa was statistically significant (p=0.003) in comparison with the intervention with 
Shunthi churna lepa. Conclusion: Gunja Beeja lepa is effective in comparison with standard anti-inflammatory 
Ayurvedic drug Shunthi in inflammatory conditions of Arthritis.
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Gunja (Abrus precatorius), a Vanaspatic Visha 
(3) is described and classified as Upavisha. (4) In India, 
it is commonly known as Ratti or Gunchi. Ratti is 
referred to a single Ratti (120mg) seed. This seed was 
the standard weight in the ancient Indian system of 
measurement, because the seed is fairly constant in 
weight. It was used to measure gold and 1 Tola 
(11.6gm) = 1 Masha; (1 Masha=8 Ratti). It is called as 
Kudri mani in Tamil and Guru ginja in Telugu. It has 
been used even in Siddha medicine for centuries. The 
seeds are much valued in native jewelry for their bright 
coloration.  
Two types, red and white Gunja are beneficial 
for many viz. cures diseases due to vitiation of Vata and 
Pitta, fever, dryness of mouth, giddiness, difficulty in 
breathing, thirst, excitement, diseases of eyes, improve 
sex vigor and bodily strength and is useful in pruritus, 
ulcer treatment, destruction of worms and similar 
parasites, nourishes hair and removes alopecia and other 
skin diseases (5) as well as rakshograhavisha. (6) It is 
indicated in atrophied ear lobule, dandruff, sciatica, 
erysepalous and few other dermatoses, blindness, 
diseases of head, dental caries, etc. (7) It is very much 
beneficial as anti-inflammatory, anti-microbial, anti-
fertility, anti-tumor etc. A paste of Gunja seeds can be 
used as rubraficient in Sciatica, stiff shoulders, paralysis 
and other nervous and arthritic conditions. (8) In 
patients of arthritis, either steroids or non steroidal anti-
inflammatory drugs (NSAID) are commonly used for 
quick relief. As the disease is a chronic, patients have to 
consume medicine for long term. Long term use of 
steroids is known to produce liver toxicity. Hence, a 
randomized clinical study was conducted to assess the 
efficacy of Gunja beeja lepa to manage the local 
inflammatory conditions of Arthritis in comparison with 
a standard anti-inflammatory Ayurvedic drug Shunthi 
(Zingiber officinalis) to provide a potent anti-
inflammatory drug for the purpose of arthritis clinical 
practice. 
Material and Methods 
Materials: 
i.Red Gunja (Abrus precatorius Linn) seeds 
ii.Shunthi  (Zingiber officinalis Linn) 
iii.Water 
iv.Measuring Tape 
v.Surface temperature measuring card 
vi.Universal Pain Assessment Scale. 
Methods 
After receiving approval from Institutional 
Ethics Committee Ref.No. DMIMS (DU)/IEC/
2012-13/5 dated 24/12/2012, a standard comparative 
randomized controlled single blinded clinical study was 
conducted under the supervision of Professor and head, 
department of Panchakarma, M.G.A.C.H. & R.C. Salod 
(H), Wardha.  
Patients ages 21-70 years, suffering from 
transient mono or bi-arthropathies of  knee i.e. having 
history of pain and swelling of either one or both joints 
with unattended short duration of history were 
randomly selected from OPD and 128 patients were 
screened. The patients were included in group A or 
group B by lottery method of randomization. Each 
group have 30 patients and the total number of included 
are 60 patients. Informed written consent was taken 
after due consultation with patients. 
Patients below 20 and above 70 years of ages, 
patients with skin diseases or lesions over the knee or 
known allergic, pre diagnosed patients with conditions 
such as Rheumatoid arthritis, Gouty arthritis, Infective 
arthritis and Diabetic arthopathy, patients having any 
traumatic history along with local abrasion, erosion, 
cuts or laceration, patients associated with simple or 
compound fractures and pregnant and lactating women 
were excluded from the study.  
Group A was treated with standard anti-
inflammatory drug Shunthi (Zingiber officinalis Linn) 
churna lepa and Group B was treated with Trial drug 
Gunja (Abrus precatorius Linn) churna lepa. 
Method of Preparation of study drug  
Red coloured variety of Gunja (Abrus 
precatorius) seed was procured from local market and 
authenticated from HOD, Dravyaguna, M.G.A.C.H. & 
R.C. Salod (H), Wardha. Physical impurities were 
separated and fully developed, undamaged seeds were 
selected. The seed coat was removed after partial 
grinding and the seed was powdered till it becomes fine 
required for paste preparing. Fine powder of Shunthi 
was prepared simultaneously by grinding. 
In physical examination, all the tender and 
swollen joints were examined and counted. Local 
temperature at joints was assessed with surface 
temperature measuring card. Circumference of joints 
was measured with metal tape. Range of movement and 
stiffness was measured with Goniometry and pain was 
assessed with Universal pain assessment Scale. 
C o m p l e t e b l o o d c o u n t , E r y t h r o c y t e 
Sedimentation Rate, Random Blood Sugar, C-Reactive 
Protein and Rheumatoid Arthritis test was conducted for 
each patient. Modified Disease activity score (DAS 
with 28 joints and three variables viz. tenderness, 
swelling and ESR) was calculated after physical and 
pathological examination as follows: 
DAS 28-3= [0.56 x √(TJC28) +0.28 x √(SJC28)+0.70 x 
ln(ESR)]1.08+0.16 
Where, TJC28 -Tender Joint Count (Range 0-28), 
SJC28 -Swollen Joint Count (Range 0-28), 
ESR-Erythrocyte sedimentation rate 
On the basis of score obtained, the condition of the 
patients was categorized as follows: 
Level of Disease Activity: 
• DAS 28 ≤ 3.2 – Low disease activity 
• 3.2 > DAS 28 <  5.1 – Moderate disease activity 
• DAS 28 ﹥ 5.1 – High disease activity 
• DAS 28 < 2.6 – Remission 
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Application of trial drug 
A freshly prepared Gunja beeja lepa in water 
was applied with applicator on lower part of the leg of 
the patient and was kept for ten minutes to observe any 
sensitivity reaction. Once there was no sensitivity 
reaction, the lepa was applied gently and evenly over 
affected area only. It was then freely allowed to dry 
neither in sunlight nor in air from fan. After getting 
dried and becoming stiff, the lepa applied was allowed 
to wash with Luke warm water. The same procedure 
was adopted for both the groups (A and B) twice a day 
under supervision in IPD. The drug application period 
was 3 or 5 or 7 days on the basis of pain or swelling 
condition. If pain or swelling was not reduced after 
three days, Lepa application was continued for two 
more days. If pain or swelling was not reduced even 
after fifth day, the application was continued for two 
more days. After seventh day, even though remains 
same the application was discontinued and listed as “No 
Response”. Thus, sets of 3, 5 and 7 days were observed, 
where the pain/swelling was the criteria to continue the 
drug application for both groups. 
Statistical analysis  
The results are presented as Mean+ Standard 
Error of means (SEM) in each group. Statistical 
comparisons were performed by both paired, unpaired 
student’s t test by using Sigma stat software (version 
3.1) for both the experimental groups at p<0.05 (level of 
significance).  
Observation and Results 
Table No.1: Total Number of Patients in study  
Table No.2: Distribution of Patients according to age and sex 
Table No.3: Effect of Shunthi Churna lepa on Disease Activity Score (DAS) in Group A 
Table No.4: Effect of Gunja beeja lepa on Disease Activity Score (DAS) in Group B 
Table No.5: Comparison of Effect on Disease Activity Score (DAS) between both groups  
Table No.6: Overall effect of treatment in both groups 
Group A Group B
Total patients enrolled 30 34
Adverse drug reaction 0 4
Group A Group B
Age group (yrs) Male Female Male Female
21-30 0 0 4 2
31-40 0 3 2 1
41-50 5 5 3 2
50-60 6 6 0 7
61-70 2 3 1 8
Total 13 (43.33%) 17 (56.66%) 10 (33.33%) 20 (66.66%)
Total 30 30
DAS Mean SD SEM Mean  difference t value p value
Before treatment 4.335 0.732 0.134 0.835 8.382 <0.001After treatment 3.500 0.780 0.142
DAS Mean SD SEM Mean  difference t value p value
Before treatment 4.339 0.850 0.155 1.510 13.437 <0.001After treatment 2.829 0.880 0.161
DAS Group Mean SD SEM Mean   difference t-value p value
Before treatment A 4.335 0.732 0.134 -0.00390 -0.0190 0.985B 4.339 0.850 0.155
After treatment A 3.500 0.780 0.142 0.671 3.127 0.003*B 2.829 0.880 0.161
Group A Group B
Before Treatment After Treatment % Before Treatment After Treatment %
Low DAS (<3.2) 2 6 20 5 9 30
Moderate DAS (< 5.1) 24 19 63.33 23 8 26.67
High DAS (> 5.1) 4 0 0 2 0 0
Remission (DAS < 2.6) 0 5 16.67 0 13 43.33
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Discussion 
Gunja (Abrus precatorius Linn) is an irritant 
vegetative poison. All the parts of Gunja are poisonous. 
But seeds are more poisonous which contain a variety 
of poisonous proteins. The most important one is Abrin, 
(9) which is highly toxic thermo labile protein 
(toxalbumin LD 50= 0.029 mg/kg body weight of mice) 
(10) present to the extent of 0.15 % in the seed. (11) 
Seeds are also used as Vranaropana, vedanasthapana, 
keshavardhana, etc. (12) 
Pharmacological properties of Gunja are katu, 
tikta, kashaya rasa; katu vipaka and ushna virya. It also 
possesses antitumor, anticancer, antispermatogenic, 
antifertility, CNS depressant and analgesic activity in 
rat. (13)  
Externally, the seed extract is used in the 
treatment of ulcers and skin affections, anti-diarrheal 
and anti-helminthitic activities. (14) 43 formulations are 
used as external applications for kustha (skin diseases), 
krimi (parasitic disease), kandu (itching), arsha (piles), 
kasa (cough), indralupta (alopecia), apavahuka (pain in 
arms), griddrasi, nasya, timiraroga (eye disease), 
nadivrana (sinus ulcers), shiroroga (disease of the 
h e a d ) , g a n d a m a l a ( c h a i n o f s w e l l i n g ) , 
karnapalivivardhana, andhattya (blindness), visarpa 
(erysepelas), dadru (skin disease), vicharchika (one 
type of skin disease), kaphaja galaganda (goitre), etc.
(15) It can cause redness with rash on skin as symptoms 
of local toxicity. If extract is administered in the skin, it 
may cause symptoms like viper snake bite and death 
within 24 hours. Internal consumption of Gunja seeds 
leads to symptoms like vishuchika (cholera). (16) 
Tanduliyaka swarasa (Amaranthus spinosus Linn) with 
sugar is described as an antidote for Gunja poisoning in 
Ayurveda. (17) 
In the present study, disease activity score 
(DAS 28-3) was assessed before and after treatment in 
both the groups. In group A with standard drug, the 
intervention with Shunthi churna lepa was statistically 
significant (p<0.001). All the patients required 
application of lepa for seven days duration.  
In group B with trial drug, the intervention with 
Gunja beeja lepa was statistically significant (p<0.001) 
and all the patients required application of lepa for 
seven days duration. But when the effect of both the 
groups were compared, it was found that intervention 
with Gunja beeja lepa was statistically significant 
(p=0.003) in comparison with the intervention with 
Shunthi churna lepa. In group B, after treatment 9 
patients (30%) had low disease activity score, 8 patients 
(26.67%) had moderate disease activity score, and 13 
patients (43.33%) had remission. In group A, only 5 
patients (16.67%) had complete remission. The disease 
activity score was only lowered in other patients of 
group A.  
Reduction in pain and swelling at joint started 
from second day of application in patients with group B 
treated with Gunja beeja lepa, whereas it was started 
from day four to five in patients of group A. The result 
of the study indicates that Gunja beeja lepa is effective 
in inflammatory conditions of arthritis in comparison 
with standard drug Shunthi churna lepa.  
Even after negative sensitivity reaction in 
enrolled patients, four patients developed severe rash, 
itching, burning sensation and redness over the area 
where Gunja beeja lepa was applied. The intervention 
was stopped immediately to these four patients. These 
adverse effects were treated with application of coconut 
oil. The patients who had not responded to coconut oil, 
Tanduliyaka swarasa (Amaranthus spinosus Linn) was 
applied to the affected area and 10 ml BD given 
internally with sugar. Then the patients had relieved 
from these adverse effects within two days. Thereafter, 
they were withdrawn from the study. The reason found 
was the long term contact with the drug. Inspite of 
proper instructions these patients had not washed the 
applied area after drying. In the present study, the 
adverse effects were manageable. Red variety of Gunja 
seeds was used without any shodhana as shodhana was 
not expected for external use. Shodhita Gunja beeja 
may not cause any adverse effect. Hence, a similar 
study can be conducted with red variety of Gunja with 
shodhana and white variety of Gunja with and without 
shodhana to avoid adverse effects. 
During the intervention, most of the patients 
experienced some dragging sensation along the nerve 
root of the area of application. Then they were feeling 
better after each setting. Ushna virya property of Gunja 
may have reduced pain and swelling at the affected 
joint. Visha dravya have laghu, ushna, tikshna, 
sookshma, ashukari and vyavayi properties (18) with 
which they are readily absorbed in the body, spread 
quickly and show immediate effect causing decrease in 
inflammation and pain at the affected joint. 
At the end of the 19th century, the extract of 
Gunja seeds was used therapeutically for its 
inflammatory properties, to treat various eye complaints 
including trachoma. But some cases of Abrin poisoning 
were also noted with local use. (19) It is observed from 
the reported cases that Gunja reduces inflammation in 
therapeutic dose and on the contrary in higher dose it 
causes inflammation. 
Conclusion 
Gunja Beeja lepa has been proved to be 
effective in comparison with standard anti-
inflammatory Ayurvedic drug Shunthi in inflammatory 
conditions of either mono or bi Arthritis. But the local 
application should be restricted for limited time only to 
avoid adverse drug reaction. Similar study can be 
conducted with red variety of Gunja with shodhana and 
white variety of Gunja with and without shodhana to 
assess their efficacy without any adverse effects. As 
Gunja has been proved efficacious for external 
application in reducing pain and inflammation, the 
liniments or spray with the ingredients of Gunja may 
open new dimensions in sports medicine to relive the 
pain and swelling instantly.  
203

International Journal of Ayurvedic Medicine, Vol 11 (2), 200-204
Published online in http://ijam.co.in 
  
ISSN No: 0976-5921
References 
1. h t t p : / / w w w. a r t h r i t i s . o rg / a b o u t - a r t h r i t i s /
understanding-arthritis/what-is-arthritis.php dated: 
05-02- 2020 time 21:15 IST. 
2. Sharma P V. Charaka Samhita of Agnivesha, 
Chikitsasthana, 7th edition, Varanasi; Chaukhambha 
Orientalia publishers; 2005. 366p 
3. Sharma Mishra Gulraj. Ayurved Prakash of 
Madhava, (6:108). Varanasi; Choukhamba Bharti 
Academy; 2007. 500p. 
4. Shastri K. Sadanand Sharma. Rasatarangini. Delhi; 
Motilal Banarasidas Publication; 1979. 676p. 
5. Pandey G. Chunekar K. Bhavprakash Nighantu, 2nd 
edition. Varanasi; Chokhamba Orientalia publisher; 
1998. 354-355p. 
6. Sharma P V. Kaidev Nighantu. Varanasi; 
Chokhamba Orientalia publisher; 148p. 
7. Sharma P V. Kaidev Nighantu. Varanasi; 
Chokhamba Orientalia publisher; 148p. 
8. Shastri K. Sharma S. Rasatarangini. Delhi; Motilal 
Banarasidas Publication; 2000. 730p. 
9. Mathiharan K, Patnaik Amrit. Modi's Medical 
Jurisprudence and Toxicology, 23rd edition. Nagpur: 
Lexis Nexis Butterworths Wadhwa, 223p. 
10. Budavari S, The merck index – An encyclopedia of 
chemicals, drugs and biologicals, Whitehouse 
Station, Merck and co, New Jersey, 1989. 
11. CDC; NI+SH Emergency Response Card: Abrin. 
April 24, 2003: http:--www.bt.cdc.gov-agentabrin-
erc13F396290.asp 
12. Garga Devisharana, Trivedi K P. Dhanwantari 
Vanausadhi Vishesanka. Aligarh: Shri Jwala 
Ayurveda Bhavan. 2004; 340–344p. 
13. Review on Indian Plants, Indian council of medical 
research. New Delhi: 2004; Vol-1, 24p. 
14. The Wealth of India, Raw Materials. A Revised 
version, Council of Scientific & Industrial 
Research, New Delhi. 2003; Vol I: 18–20. 
15. Acharya Rabinarayan, Roy  Sudipta. A Review on 
Therapeutic Utilities and Purificatory Procedure of 
Gunja (Abrus precatorius Linn.) as Described in 
Ayurveda, Research & Reviews: Journal of 
Agricultural Science & Technology. 2(1); 1-12.  
16. Shastri K, Sharma S. Rasatarangini, Delhi; Motilal 
Banarasidas Publication. 2000. 728p.  
17. Mishra Bramhashankar. Bhavprakash Nighantu. 
Varanasi; Choaukhambha Sanskrit Bhavan. Reprint. 
356p. 
18. Sharma P V. Charaka Samhita of Agnivesha. 7th 
edition. Varanasi; Chaukhambha Orientalia 
publishers; 2005. 366p. 
19. Kirsten J. D, Sally M. B, Paul R, Gareth D. G. and 
Allister J.V, Abrin Poisoning. Toxicol Rev 2003; 22 
(3); 137-142. 
*****
204
